Aristo Pharma announces an equity financing agreement with VaRi Bioscience
Aristo Pharma gladly announces the signature of an equity financing agreement with VaRi Bioscience. Based on the agreement, Aristo Pharma is joining as shareholder of VaRi Bioscience GmbH. VaRi Bioscience will continue to develop its long-acting vaginal ring pipeline with a special focus on the development of the lead product VR102.